LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Cerberus Therapeutics

Similar companies to Cerberus Therapeutics

Cerberus Therapeutics Tech Stack

Cerberus Therapeutics uses 5 technology products and services including Wix, Google Cloud, React, and more. Explore Cerberus Therapeutics's tech stack below.

  • Wix
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • React
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • Lodash
    Javascript Libraries

Media & News

Cerberus Therapeutics's Email Address Formats

Cerberus Therapeutics uses at least 1 format(s):
Cerberus Therapeutics Email FormatsExamplePercentage
FLast@cerberustx.comJDoe@cerberustx.com
50%
FLast@cerberustx.comJDoe@cerberustx.com
50%

Frequently Asked Questions

Where is Cerberus Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Cerberus Therapeutics's main headquarters is located at 700 Main St Cambridge, Massachusetts 02139 US. The company has employees across 1 continents, including North America.

What is Cerberus Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Cerberus Therapeutics's official website is cerberustx.com and has social profiles on LinkedIn.

How much revenue does Cerberus Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Cerberus Therapeutics's annual revenue reached $750K.

What is Cerberus Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cerberus Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cerberus Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Cerberus Therapeutics has approximately 7 employees across 1 continents, including North America. Key team members include Acting Chief Technology Officer: T. H.Co-Founder: N. P.Senior Scientist: L. P.. Explore Cerberus Therapeutics's employee directory with LeadIQ.

What industry does Cerberus Therapeutics belong to?

Minus sign iconPlus sign icon
Cerberus Therapeutics operates in the Biotechnology Research industry.

What technology does Cerberus Therapeutics use?

Minus sign iconPlus sign icon
Cerberus Therapeutics's tech stack includes WixGoogle CloudReactPolyfillLodash.

What is Cerberus Therapeutics's email format?

Minus sign iconPlus sign icon
Cerberus Therapeutics's email format typically follows the pattern of . Find more Cerberus Therapeutics email formats with LeadIQ.

When was Cerberus Therapeutics founded?

Minus sign iconPlus sign icon
Cerberus Therapeutics was founded in 2022.
Cerberus Therapeutics

Cerberus Therapeutics

Biotechnology ResearchMassachusetts, United States2-10 Employees

Cerberus Therapeutics utilizes nanobody-based platform to create novel therapeutics for modulating the immune system.

The COVID-19 pandemic highlights the need for safe and accessible therapies to modulate our immune responses. We have developed strategies that allows for precise turning on/off the immune system in response to debilitating diseases.

Our pilot programs focus on autoimmune disorders and infectious diseases, that are based on novel biological discoveries originating from decades of work by our three founders: Dr. Novalia Pishesha, Prof. Hidde Ploegh, and Prof. Harvey Lodish.

Section iconCompany Overview

Headquarters
700 Main St Cambridge, Massachusetts 02139 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2022
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    Cerberus Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Cerberus Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.